(RTTNews) - Medtronic plc (MDT) announced the U.S. Food and Drug Administration approval for Simplera continuous glucose monitor, or CGM, the company's first disposable, all-in-one CGM that's half the ...
Medtronic Diabetes has received approval from the US Food and Drug Administration (FDA) for a new continuous glucose monitoring (CGM) device and has also partnered with Abbott Diabetes Care for a ...
Medtronic’s (NYSE:MDT) Simplera continuous glucose monitor (CGM) has received regulatory approval from the U.S. Food and Drug Administration (FDA). Simplera is the company's first disposable, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Simplera CGM features a one-hand, two-step insertion ...
Medtronic has earned FDA approval that will allow it to broaden the scope of its MiniMed 780G system portfolio. FDA has cleared Medtronic’s SmartGuard algorithm as an interoperable automated glycemic ...
The FDA has approved Medtronic’s MiniMed 780G automated insulin delivery (AID) system for use in type 2 diabetes (T2D). At the same time, FDA also cleared the MiniMed SmartGuard algorithm as an ...
DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ ...
Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global ...
Medtronic plc MDT recently announced the commercial launch of the MiniMed Go Smart MDI system with the Simplera sensor in Europe. The system brings together data from the InPen smart insulin pen and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results